Professors Gin Malhi and Gregory Mattingly discuss the importance balancing treatment efficacy and tolerability when starting therapy in schizophrenia, then review when to consider a long-acting injectable and which patients are suitable.
The views and opinions expressed in this video do not necessarily reflect those of Lundbeck and Otsuka.
Page: AU-ABIM-0586. September 2024. Video: AU-ABIM-0527. March 2024.
